scholarly journals Faculty Opinions recommendation of First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

2018 ◽  
Author(s):  
Milan Chheda
Keyword(s):  
Clinical Trial ◽  
Dendritic Cell ◽  
Dendritic Cell Vaccine ◽  
Cell Vaccine ◽  
Newly Diagnosed ◽  
Autologous Dendritic Cell ◽  
Phase 3 ◽  
First Results ◽  
Newly Diagnosed Glioblastoma ◽  
Large Phase

scholarly journals ATIM-13. ALLOGENEIC TUMOR LYSATE/AUTOLOGOUS DENDRITIC CELL VACCINES IN NEWLY DIAGNOSED GLIOBLASTOMA: RESULTS OF CLINICAL TRIAL MC1272

2017 ◽  
Vol 19 (suppl_6) ◽  
pp. vi28-vi29 ◽  
Author(s):  
Ian F Parney ◽  
Michael P Gustafson ◽  
Timothy Peterson ◽  
Susan M Steinmetz ◽  
Allan B Dietz
Keyword(s):  
Clinical Trial ◽  
Dendritic Cell ◽  
Newly Diagnosed ◽  
Autologous Dendritic Cell ◽  
Tumor Lysate ◽  
Allogeneic Tumor ◽  
Dendritic Cell Vaccines ◽  
Newly Diagnosed Glioblastoma

scholarly journals Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma

2012 ◽  
Vol 62 (1) ◽  
pp. 125-135 ◽  
Author(s):  
Surasak Phuphanich ◽  
Christopher J. Wheeler ◽  
Jeremy D. Rudnick ◽  
Mia Mazer ◽  
HongQian Wang ◽  
...  
Keyword(s):  
Dendritic Cell ◽  
Phase I ◽  
Phase I Trial ◽  
Dendritic Cell Vaccine ◽  
Cell Vaccine ◽  
Newly Diagnosed ◽  
Newly Diagnosed Glioblastoma
Sign in / Sign up

Export Citation Format

Share Document